Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

SHE:002873 Revenue

Guiyang Xintian Pharmaceutical had revenue of 171.67M CNY in the quarter ending September 30, 2026, a decrease of -14.32%. This brings the company's total for the last twelve months to 694.58M, down -8.04% year-over-year. In the year 2025, Guiyang Xintian Pharmaceutical had annual revenue of 749.72M, down -12.57%. That makes Guiyang Xintian Pharmaceutical the 22,382nd largest company in the world by revenue and 4,093rd in China.

• Revenue (ttm): 694.58M
• Revenue Growth: -8.04%
• P/S Ratio: 2.60
• Revenue / Employee: 500.42K
• Employees: 1,388
• Market Cap: 1.80B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	749.72M	-107.83M	-12.57%
Dec 31, 2024	857.55M	-96.43M	-10.11%
Dec 31, 2023	953.98M	-133.69M	-12.29%
Jan 1, 2023	1.09B	117.83M	12.15%
Jan 1, 2022	969.84M	218.90M	29.15%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error